Gp Act Iii Acquisition Stock Net Income
| GPAT Stock | 10.11 0.03 0.30% |
GP Act III Acquisition fundamentals help investors to digest information that contributes to GP Act's financial success or failures. It also enables traders to predict the movement of GPAT Stock. The fundamental analysis module provides a way to measure GP Act's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to GP Act stock.
| Last Reported | Projected for Next Year | ||
| Net Loss | -14 K | -14.7 K | |
| Net Loss | -14 K | -14.7 K |
GPAT |
GP Act III Acquisition Company Net Income Analysis
GP Act's Net income is the profit of a company for the reporting period, which is derived after taking revenues and gains and subtracting all expenses and losses. Net income is one of the most-watched numbers by money managers as well as individual investors.
Current GP Act Net Income | (14.04 K) |
Most of GP Act's fundamental indicators, such as Net Income, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, GP Act III Acquisition is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Because income is reported on the Income Statement of a company and is measured in dollars some investors prefer to use Profit Margin, which measures income as a percentage of sales.
| Competition |
Based on the recorded statements, GP Act III Acquisition reported net income of (14,041). This is 100.0% lower than that of the Financial Services sector and 100.0% lower than that of the Financials industry. The net income for all United States stocks is 100.0% higher than that of the company.
GPAT Net Income Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses GP Act's direct or indirect competition against its Net Income to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of GP Act could also be used in its relative valuation, which is a method of valuing GP Act by comparing valuation metrics of similar companies.GP Act is currently under evaluation in net income category among its peers.
GPAT Fundamentals
| Current Valuation | 362.14 M | ||||
| Shares Outstanding | 28.75 M | ||||
| Shares Owned By Institutions | 40.32 % | ||||
| Number Of Shares Shorted | 3.41 K | ||||
| Price To Book | 1.30 X | ||||
| EBITDA | (14.04 K) | ||||
| Net Income | (14.04 K) | ||||
| Total Debt | 628.18 K | ||||
| Book Value Per Share | (0.02) X | ||||
| Cash Flow From Operations | (10.97 K) | ||||
| Short Ratio | 0.11 X | ||||
| Earnings Per Share | 0.15 X | ||||
| Market Capitalization | 362.25 M | ||||
| Total Asset | 530.24 K | ||||
| Retained Earnings | (122.94 K) | ||||
| Working Capital | (624.87 K) | ||||
| Net Asset | 530.24 K |
About GP Act Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze GP Act III Acquisition's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of GP Act using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of GP Act III Acquisition based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for GPAT Stock Analysis
When running GP Act's price analysis, check to measure GP Act's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy GP Act is operating at the current time. Most of GP Act's value examination focuses on studying past and present price action to predict the probability of GP Act's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move GP Act's price. Additionally, you may evaluate how the addition of GP Act to your portfolios can decrease your overall portfolio volatility.